Sensorion

Sensorion

Developing life-transforming therapies for patients with inner ear disorders involving vertigo and hearing loss
Montpellier France (HQ), Clapiers France

Sensorion Company information

Edit
Date
Employees
26 people
Market cap
€92m
Net debt
€1m
Firm valuation
€92m (Public information from 2020)
EUR20162017201820192020E2021E2022E
Revenues-2m2m3m6m3m-
% growth---50 %100 %(50 %)-
EBITDA-(9m)(12m)(14m)(16m)--
% EBITDA margin-(450 %)(600 %)(467 %)(267 %)--
Profit-(9m)(12m)(12m)(19m)(20m)-
% profit margin-(450 %)(600 %)(400 %)(317 %)(667 %)-
EV / Revenue--4.5x7.1x15.7x34.6x-
EV / EBITDA---0.9x----
  • Edit
DateInvestorsAmountRound
-N/A
€4mSERIES A
N/A€8.3m
IPO*
*
€8.6mPOST IPO EQUITY
N/A€20mPOST IPO DEBT
*
€18.1mGROWTH EQUITY
Total Funding€23.2m

Recent News about Sensorion

Edit
LocationEdit
375 Blayac, Rue du Professeur Joseph Anglada, 34080 Montpellier, France
Are you an employee or an investor of this company?
Add your profile